| Photographic Evidence of Oral Precancerous Lesions in Current Tobacco and Areca Nut Users Improves Their Quit Rates (NCT05215860) | All India Institute of Medical Sciences | 2020-09-01 |
| Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization (NCT04065737) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2019-08-15 |
| Oral Epithelial Dysplasia Informational Needs Questionnaire (NCT04153266) | University College, London | 2018-10-31 |
| Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3) (NCT03100045) | Johns Hopkins University | 2017-04-20 |
| A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies (NCT02158858) | Constellation Pharmaceuticals | 2014-07-16 |
| Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions (NCT02323672) | Cairo University | 2014-02-01 |
| Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2 (NCT01837693) | Azienda USL Reggio Emilia - IRCCS | 2013-06-01 |
| Early Diagnosis of Pulmonary Nodules (NCT01752114) | Integrated Diagnostics | 2012-10-01 |
| Identification of a Plasma Proteomic Signature for Lung Cancer (NCT01752101) | Integrated Diagnostics | 2012-10-01 |
| Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy (NCT00851305) | Shandong University | 2008-08-01 |
| Oral Cancer Screening in Mumbai, India by Primary Health Care Workers (NCT00655421) | Tata Memorial Hospital | 2008-04-01 |
| Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor (NCT00314262) | Emory University | 2006-10-01 |
| Natural History of Oro-pharyngeal Cancer Precursors (NCT00179361) | Albert Einstein College of Medicine | 2004-11-01 |
| Collection of Blood, Bone Marrow, Tumor or Tissue Samples (NCT00043615) | National Cancer Institute (NCI) | 2002-07-29 |
| Follow-up Modalities of Low Grade Precancerous Bronchial Lesions (NCT00213603) | University Hospital, Rouen | 2002-04-01 |
| Chemoprevention of Oral Premalignant Lesions (NCT00036283) | Pfizer | 2000-11-01 |